Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenQuadfi vs Nimenrix in Healthy Infants and Toddlers (1+1 Schedule)
NCT06284915Phase 3Completed
- Sponsor
- Sanofi
- Start
- Mar 2024
- Primary completion
- Nov 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 6
01
Overview
A Phase 3 trial of meningococcal A conjugate vaccine in meningococcal infection, sponsored by Sanofi. Started Mar 2024; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT06284915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06284915.